Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

Similar articles for PubMed (Select 23029498)


Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity.

Albarrak SM, Brown WC, Noh SM, Reif KE, Scoles GA, Turse JE, Norimine J, Ueti MW, Palmer GH.

PLoS One. 2012;7(9):e46372. doi: 10.1371/journal.pone.0046372. Epub 2012 Sep 28.


Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.

Lopez JE, Palmer GH, Brayton KA, Dark MJ, Leach SE, Brown WC.

Infect Immun. 2007 May;75(5):2333-42. Epub 2007 Mar 5.


Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge.

Noh SM, Turse JE, Brown WC, Norimine J, Palmer GH.

Clin Vaccine Immunol. 2013 May;20(5):651-6. doi: 10.1128/CVI.00600-12. Epub 2013 Feb 27.


Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine.

Agnes JT, Brayton KA, LaFollett M, Norimine J, Brown WC, Palmer GH.

Infect Immun. 2011 Mar;79(3):1311-8. doi: 10.1128/IAI.01174-10. Epub 2010 Dec 28.


Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.

Nuñez PA, Moretta R, Ruybal P, Wilkowsky S, Farber MD.

Curr Microbiol. 2014 Mar;68(3):269-77. doi: 10.1007/s00284-013-0475-6. Epub 2013 Oct 15.


Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization.

Noh SM, Brayton KA, Brown WC, Norimine J, Munske GR, Davitt CM, Palmer GH.

Infect Immun. 2008 May;76(5):2219-26. doi: 10.1128/IAI.00008-08. Epub 2008 Mar 3.


The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity.

Noh SM, Zhuang Y, Futse JE, Brown WC, Brayton KA, Palmer GH.

Vaccine. 2010 May 7;28(21):3741-7. doi: 10.1016/j.vaccine.2010.02.067. Epub 2010 Mar 1.


Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping.

Lopez JE, Siems WF, Palmer GH, Brayton KA, McGuire TC, Norimine J, Brown WC.

Infect Immun. 2005 Dec;73(12):8109-18.


Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in mice.

Santos PS, Sena AA, Nascimento R, Araújo TG, Mendes MM, Martins JR, Mineo TW, Mineo JR, Goulart LR.

PLoS One. 2013 Apr 8;8(4):e60311. doi: 10.1371/journal.pone.0060311. Print 2013.


Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale.

Dark MJ, Al-Khedery B, Barbet AF.

Vaccine. 2011 Jul 12;29(31):4923-32. doi: 10.1016/j.vaccine.2011.04.131. Epub 2011 May 17.


IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.

Araújo FR, Costa CM, Ramos CA, Farias TA, Souza II, Melo ES, Elisei C, Rosinha GM, Soares CO, Fragoso SP, Fonseca AH.

Mem Inst Oswaldo Cruz. 2008 Mar;103(2):186-90.


High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation.

Lopez JE, Beare PA, Heinzen RA, Norimine J, Lahmers KK, Palmer GH, Brown WC.

J Immunol Methods. 2008 Mar 20;332(1-2):129-41. doi: 10.1016/j.jim.2007.12.018. Epub 2008 Jan 28.


Selection for simple major surface protein 2 variants during Anaplasma marginale transmission to immunologically naïve animals.

Palmer GH, Futse JE, Leverich CK, Knowles DP Jr, Rurangirwa FR, Brayton KA.

Infect Immun. 2007 Mar;75(3):1502-6. Epub 2006 Dec 18.


Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale.

Brayton KA, Palmer GH, Brown WC.

Expert Rev Vaccines. 2006 Feb;5(1):95-101. Review.


Evaluation of humoral and cellular immune response of BALB/c mice immunized with a recombinant fragment of MSP1a from Anaplasma marginale using carbon nanotubes as a carrier molecule.

Silvestre BT, Rabelo ÉM, Versiani AF, da Fonseca FG, Silveira JA, Bueno LL, Fujiwara RT, Ribeiro MF.

Vaccine. 2014 Apr 17;32(19):2160-6. doi: 10.1016/j.vaccine.2014.02.062. Epub 2014 Mar 4.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk